Society


Posts filtered by tags: Oxford AstraZeneca[x]


 

UK Covid cases could rise again despite vaccine progress – WHO official

Exclusive: Dr Catherine Smallwood says there is potential for surge unconnected to increases in EuropeThe success of Britain’s vaccine programme is not enough to protect it from another wave of coronavirus unconnected to rising cases in Europe, a senior World Health Organization expert has said.Dr Catherine Smallwood, a senior emergency officer at WHO Europe, also said confidence in vaccines may have dipped after changes to the Oxford/AstraZeneca jab rollout, with under-30s to be offered alterna...
Tags: Health, Europe, Politics, UK, Society, UK News, Britain, Health policy, World Health Organization, Vaccines and immunisation, WHO Europe, Catherine Smallwood, Coronavirus, Oxford AstraZeneca


Vaccine confidence fears as under-30s in UK offered AstraZeneca alternative

Experts warn of impact after advice changes in response to 79 blood clot cases out of 20m vaccinationsJab fears may play into hands of anti-vaxxersCoronavirus – latest UK updatesSee all our coronavirus coverageExperts warned of damage to confidence in the UK’s vaccine programme after 10 million adults under 30 were told they will be offered an alternative to the Oxford/AstraZeneca jab following concerns over rare blood clots.Healthy 18- to 29-year-olds who are not at high risk of Covid should ha...
Tags: Health, UK, Science, Society, UK News, World news, Medical Research, Infectious Diseases, Astrazeneca, Vaccines and immunisation, JCVI, Coronavirus, Oxford AstraZeneca


Alternative to Oxford/AstraZeneca could damage vaccine confidence, say experts

Option offered to under-30s after UK records 79 cases of rare blood clots out of 20m jabs administeredJab fears may play into hands of anti-vaxxersCoronavirus – latest UK updatesSee all our coronavirus coverageExperts warned of damage to confidence in the UK’s vaccine programme after 10 million adults under 30 were told they will be offered an alternative to the Oxford/AstraZeneca jab following concerns over rare blood clots.Healthy 18- to 29-year-olds who are not at high risk of Covid should ha...
Tags: Health, UK, Science, Society, UK News, World news, Medical Research, Infectious Diseases, Vaccines and immunisation, JCVI, Coronavirus, Oxford AstraZeneca


AstraZeneca Covid vaccine: weighing up the risks and rewards

Despite scientific advice to continue getting the jab, answers about fatal blood clots are urgently neededCoronavirus – latest updatesSee all our coronavirus coverageVaccines have side-effects, as do all medicines. Most often, jabs cause sore arms, a headache or a bit of nausea – none of which would be very significant when weighed against the toll of a serious virus such as Covid-19.But sometimes the risk-benefit calculation may look less simple, as in the case of Oxford/AstraZeneca’s Covid jab...
Tags: Health, Europe, UK, Society, UK News, Medical Research, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, Coronavirus, Oxford AstraZeneca


Oxford/AstraZeneca jab could have causal link to rare blood clots, say UK experts

Evidence ‘consistent with causality’ but vaccination programme must continue, says drug safety specialistCoronavirus – latest updatesSee all our coronavirus coverageDrug safety experts in the UK believe there could be a causal link between the Oxford/AstraZeneca Covid jab and very rare blood clots but say vaccination programmes must continue, with risk mitigation for women under 55.Prof Saad Shakir, the director of the drug safety research unit (DSRU) at Southampton University, said the evidence...
Tags: Health, Europe, Politics, UK, Society, UK News, World news, Oxford, Health policy, Vaccines and immunisation, Southampton University, Coronavirus, Oxford AstraZeneca, Saad Shakir, DSRU


EU drug agency denies already finding causal link between AstraZeneca vaccine and blood clots

European Medicines Agency says review ongoing after head of vaccines spoke of ‘clear’ associationCoronavirus – latest updatesSee all our coronavirus coverageEurope’s drug regulator has denied it has already established a causal connection between the Oxford/AstraZeneca vaccine and a rare blood clotting syndrome, after a senior official from the agency said there was a link.In a statement to Agence France-Presse, the European Medicines Agency (EMA) said on Tuesday it had “not yet reached a conclu...
Tags: Health, Europe, Eu, European Union, Society, Infectious Diseases, Astrazeneca, Vaccines and immunisation, European Medicines Agency, Coronavirus, Oxford AstraZeneca


Covid: seven deaths reported in Oxford/AstraZeneca UK recipients

Experts say numbers of rare blood clots remain low and benefits of vaccine far outweigh risks of Covid-19 infectionCoronavirus – latest updatesSee all our coronavirus coverageFurther cases of a rare blood clotting syndrome and seven deaths have been reported among recipients of the Oxford/AstraZeneca jab in the UK, although experts say the numbers remain low and the benefits of the vaccine far outweigh any risks.The Medicines and Healthcare products Regulatory Agency (MHRA), runs a “yellow card”...
Tags: Health, UK, Society, UK News, World news, Oxford, Astrazeneca, Vaccines and immunisation, Regulatory Agency MHRA, Medicines and Healthcare, Coronavirus, Oxford AstraZeneca


Experts stress vaccine benefits outweigh risks after seven UK deaths

30 reported cases of blood-clotting issues after AstraZeneca Covid-19 jab out of 18m dosesCoronavirus – latest updatesSee all our coronavirus coverageFurther cases of a rare blood clotting syndrome including seven deaths have been reported among recipients of the Oxford/AstraZeneca jab in the UK, although experts say the numbers remain low and the benefits of the vaccine far outweigh any risks.The Medicines and Healthcare products Regulatory Agency (MHRA), runs a “yellow card” scheme to pick up ...
Tags: Health, UK, Society, UK News, World news, Astrazeneca, Vaccines and immunisation, Regulatory Agency MHRA, Medicines and Healthcare, Coronavirus, AstraZeneca COVID, Oxford AstraZeneca


Seven UK recipients of Oxford jab reported dead after clotting

Experts say numbers of rare blood clots remain low and benefits of Covid vaccine far outweigh risksCoronavirus – latest updatesSee all our coronavirus coverageFurther cases of a rare blood clotting syndrome including seven deaths have been reported among recipients of the Oxford/AstraZeneca jab in the UK, although experts say the numbers remain low and the benefits of the vaccine far outweigh any risks.The Medicines and Healthcare products Regulatory Agency (MHRA), runs a “yellow card” scheme to...
Tags: Health, UK, Society, UK News, World news, Oxford, Astrazeneca, Vaccines and immunisation, Regulatory Agency MHRA, Medicines and Healthcare, Coronavirus, Oxford AstraZeneca


Covid vaccine side-effects: what are they, who gets them and why? | Nicola Davis

Most side-effects are mild and short-lived, and some groups are more likely to get them than othersCoronavirus – latest updatesSee all our coronavirus coverageAccording to Public Health England, most side-effects from the Covid vaccines – Pfizer/BioNTech and Oxford/AstraZeneca – are mild and short-lived. These include soreness where the jab was given, feeling tired or achy and headaches. Uncommon side-effects include having swollen lymph nodes. Continue reading...
Tags: Health, Science, Society, UK News, Vaccines and immunisation, Public Health England, Nicola Davis, Coronavirus, Pfizer BioNTech, Oxford AstraZeneca


Covax delivers first Covid vaccines in 'momentous occasion'

Doses land in Accra as part of scheme seeking to offset ‘vaccine nationalism’ Coronavirus – latest updatesSee all our coronavirus coverageCovax has delivered its first Covid-19 doses in a milestone for the ambitious programme that seeks to offset “vaccine nationalism” by wealthy countries and ensure poor ones do not wait years to start inoculating people.An aircraft carrying 600,000 doses of the Oxford/AstraZeneca vaccine landed in Accra, the capital of Ghana, on Wednesday, where jabs will be ad...
Tags: Health, Science, Society, World news, Medical Research, Infectious Diseases, Microbiology, Vaccines and immunisation, Ghana, Accra, Abidjan Ivory Coast, Coronavirus, Oxford AstraZeneca


First Covax coronavirus vaccines delivered to Ghanaian capital

Scheme seeks to offset ‘vaccine nationalism’ and ensure poor countries do not face delaysCoronavirus – latest updatesSee all our coronavirus coverageCovax has delivered its first Covid-19 doses in a milestone for the ambitious programme that seeks to offset “vaccine nationalism” by wealthy countries and ensure poor ones do not wait years to start inoculating people.An aircraft carrying 600,000 doses of the Oxford-AstraZeneca vaccine landed in Accra, the capital of Ghana, on Wednesday, where jabs...
Tags: Health, Science, Society, World news, Medical Research, Infectious Diseases, Microbiology, Vaccines and immunisation, Ghana, Accra, Abidjan, Coronavirus, Oxford AstraZeneca


A series of knocks: Oxford/AstraZeneca's bumpy road to Covid vaccine confidence

From doubts about safety in older people to questions about variants, scientists have faced a battle to convince the public and regulatorsCoronavirus – latest updatesSee all our coronavirus coverageThe Oxford University/AstraZeneca vaccine against Covid has barely been out of the news from the moment the race to protect the world’s population from the novel coronavirus began. But not always in a good way.Talented scientists at the Jenner Institute at Oxford University, led by Prof Sarah Gilbert,...
Tags: Health, Business, Science, Society, World news, Regulators, Medical Research, Infectious Diseases, Higher Education, Pharmaceuticals industry, Vaccines and immunisation, University of Oxford, Wuhan, Sarah Gilbert, Jenner Institute at Oxford University, Coronavirus


Matt Hancock almost blows it with a mention of borders and quarantine

The health secretary tries to stay upbeat despite the bad news about the South African variant Coronavirus – latest updatesSee all our coronavirus coverageIt had all been going so well. The government was on track to vaccinate the top four priority groups within the timeframe it had promised. Something that had astonished even Matt Hancock, one of the most naturally optimistic members of the cabinet. But then had come the bad news. Initial trials had suggested the Oxford/AstraZeneca vaccine didn...
Tags: Health, Politics, Society, UK News, Health policy, Hancock, Matt Hancock, Coronavirus, Oxford AstraZeneca


Covid vaccine booster may be needed as variants emerge, says minister

Nadhim Zahawi suggests annual vaccines or autumn booster could help keep on top of mutating virusCoronavirus – latest updatesSee all our coronavirus coverageThe vaccines minister, Nadhim Zahawi, has said people may need a Covid booster jab in autumn as more variants of the virus emerge, although the government is still confident current vaccines will prevent severe symptoms.His comments came following the release of a study showing the Oxford/AstraZeneca jab has reduced efficacy against the Sout...
Tags: Health, Politics, Science, Biology, Society, UK News, Medical Research, Infectious Diseases, Microbiology, Vaccines and immunisation, Nadhim Zahawi, Coronavirus, Oxford AstraZeneca


Why experts say there is no basis to claims in Germany about efficacy of AstraZeneca vaccine

Drug company and scientific partners at Oxford University have strongly pushed back against German press reportCoronavirus – latest updatesSee all our coronavirus coverageA row has broken out after German newspapers suggested the Oxford/AstraZeneca vaccine might have a lower efficacy among the over-65s. Below we take a look at the claims, and whether we should be concerned. Continue reading...
Tags: Health, Science, Biology, Germany, Society, UK News, World news, Medical Research, Infectious Diseases, Microbiology, Astrazeneca, Older people, Vaccines and immunisation, University of Oxford, Oxford University, Coronavirus


Welsh leader defends staggered rollout of Pfizer Covid vaccine

Mark Drakeford says it would be ‘logistically damaging’ to use up supply too soonCoronavirus – latest updatesSee all our coronavirus coverageThe deployment of tens of thousands of Pfizer/BioNTech vaccinations in Wales is being staggered to avoid staff sitting around with nothing to do once they get through their current supplies, the first minister, Mark Drakeford, has said.Some vaccinations in Wales may also be delayed because a batch of 26,000 Oxford/AstraZeneca vaccines earmarked for the coun...
Tags: Health, Politics, Wales, Society, UK News, Pfizer, Welsh politics, Mark Drakeford, Coronavirus, Oxford AstraZeneca


UK coronavirus live: new high of 1,325 daily recorded deaths; NHS staff to be vaccinated 'immediately'

Latest updates: latest figure represents highest number of deaths reported in one day; NHS staff to be offered jabs after growing concern from health professionalsSadiq Khan declares Covid emergency in LondonBehave as if you have Covid, virus expert tells people in EnglandModerna Covid vaccine approved for use by UK medicines regulatorWhy is Covid so bad in the UK and when will cases decline?Coronavirus global updates - live 6.17pm GMT The UK is seeing record numbers of people testing positi...
Tags: Health, Politics, UK, England, Society, UK News, World news, NHS, Boris Johnson, Khan, Nicola Davis, Coronavirus, Oxford AstraZeneca, Linda Geddes


Covid vaccine: Oxford man, 82, first in world to get Oxford/AstraZeneca jab

Dialysis patient Brian Pinker received jab at Oxford’s Churchill hospital on Monday morning Coronavirus – latest updatesSee all our coronavirus coverageAn 82-year-old retired maintenance manager has become the first person in the world outside clinical trials to get the vaccine developed by Oxford University and AstraZeneca.Speaking after getting the jab at Oxford’s Churchill hospital at 7.30am, Brian Pinker, 82, said: “The vaccine means everything to me. To my mind, it’s the only way of getting...
Tags: Health, Science, Society, World news, Medical Research, Infectious Diseases, Oxford, Astrazeneca, Vaccines and immunisation, University of Oxford, Oxford University, Coronavirus, Oxford AstraZeneca, Brian Pinker


UK to begin using Oxford Covid vaccine as PM strikes hopeful tone

Boris Johnson says he hopes pace of vaccination can be ramped up to protect tens of millions in months Coronavirus – latest updatesSee all our coronavirus coveragePeople in the UK will begin receiving the Oxford/AstraZeneca vaccine on Monday, after the prime minister expressed hope that the pace could be ramped up to protect tens of millions of people from Covid-19 within the next few months.In England the first doses would be administered in a small number of hospitals for surveillance purposes...
Tags: Health, Politics, UK, England, Science, Society, UK News, Public services policy, Hospitals, Infectious Diseases, NHS, Oxford, Doctors, Health policy, Boris Johnson, Gps


Analysis: is it wise for England to mix and match Covid vaccines?

US experts warn against plan to give different second jab if supplies run lowCoronavirus – latest updatesSee all our coronavirus coverageThe UK is setting the pace around the world in the approval and use of Covid vaccines but, while other countries watch intently, not all are yet prepared to embrace what looks like public health pragmatism rather than strict adherence to evidence.Britain is the first country in the world to approve and use the Oxford/AstraZeneca vaccine, just as it was first wi...
Tags: Health, UK, England, Science, US, Society, UK News, World news, Regulators, US news, Britain, NHS, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, Pfizer


The Oxford Covid jab is delivered this week. But when will vaccines bring results?

Fall or rise in coronavirus cases will not initially be a good measure of efficacy, say scientists devising ways to audit progressWhy is Britain delaying second doses of vaccine?Coronavirus – latest updatesSee all our coronavirus coveragePeople in Britain are set to get their first shots of the Oxford/AstraZeneca vaccine on Monday, with millions of doses being given over the next few months. The mass vaccination of the UK’s population should bring an end to the country’s Covid-19 misery, but how...
Tags: Health, UK, Society, UK News, World news, Medical Research, Britain, Infectious Diseases, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, Coronavirus, Oxford AstraZeneca


What difference will Oxford/AstraZeneca vaccine make in UK?

We look at how the introduction of a new vaccine in the fight against Covid will workCoronavirus – latest updatesSee all our coronavirus coverageThe Oxford/AstraZeneca vaccine is central to the government’s plans for ending social distancing in the UK and returning to some sort of normality. It has invested in seven different vaccines, but the biggest order is for 100m doses of the AstraZeneca jab, most of which will be manufactured in the UK. While the prime minister was jubilant that the UK wa...
Tags: Health, UK, Science, Society, UK News, Public services policy, Infectious Diseases, Health policy, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, Pfizer, University of Oxford, Coronavirus, COVID, Oxford AstraZeneca


BioNTech criticises EU failure to order enough Covid vaccine

Firm races to fill potential gap left by bloc’s gamble on several vaccines being approvedCoronavirus – latest updatesSee all our coronavirus coverageBioNtech has criticised the EU’s failure to order more doses of its coronavirus vaccine, saying it is now racing with its US partner, Pfizer, to boost production amid fears of a European “gap” left by the lack of other approved vaccines.The Pfizer/BioNTech vaccine was the first to be approved by the bloc late last month, after being accepted by the ...
Tags: Europe, France, Germany, US, Eu, European Union, Society, World news, Pharmaceuticals industry, Vaccines and immunisation, Pfizer, UK Canada, Moderna, Coronavirus, Oxford AstraZeneca


Different age groups may get different Covid vaccines, experts say

Oxford/AstraZeneca planning new trial of lower-dose jab to see how well it works in older peopleCoronavirus – latest updatesSee all our coronavirus coverageConcerns around the efficacy of the Oxford University/AstraZeneca coronavirus jab in older people could lead to different age groups being given different vaccines, experts have said.The partners announced last week that the vaccine had a 70% efficacy overall. For most trial participants – given two full doses, spaced a month apart – the effi...
Tags: Health, Business, Science, Education, Society, World news, Medical Research, Infectious Diseases, Higher Education, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, University of Oxford, Coronavirus, Oxford University AstraZeneca, Oxford AstraZeneca


Oxford AstraZeneca vaccine to be sold to developing countries at cost price

Jab that is part of global initiative to distribute doses will remain at low price ‘in perpetuity’Coronavirus – latest updatesSee all our coronavirus coverageThe coronavirus vaccine produced by Oxford University and AstraZeneca will be available on a non-profit basis “in perpetuity” to low- and middle-income countries in the developing world.The details of arrangements to supply poorer countries came as AstraZeneca revealed the interim results of a phase 3 trial of the vaccine, which is being he...
Tags: Health, Science, Society, World news, Medical Research, Infectious Diseases, Global development, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, University of Oxford, Oxford University, Coronavirus, Oxford AstraZeneca


Oxford AstraZeneca vaccine will be sold to developing countries at cost price

Jab that is part of global initiative to distribute doses will remain at low price ‘in perpetuity’Coronavirus – latest updatesSee all our coronavirus coverageThe coronavirus vaccine produced by Oxford University and AstraZeneca will be available at cost – not for profit – “in perpetuity” to low and middle income countries in the developing world.The details of arrangements to supply poorer countries came as AstraZeneca revealed the interim results of phase 3 trial of a vaccine that is being hera...
Tags: Health, Science, Society, World news, Medical Research, Infectious Diseases, Global development, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, University of Oxford, Oxford University, Coronavirus, Oxford AstraZeneca


Covid: Oxford AstraZeneca vaccine has up to 90% efficacy, data reveals

Vaccine developed in UK by AstraZeneca and Oxford University ‘will save many lives’, says scientistCoronavirus – latest updatesSee all our coronavirus coverageThe Covid vaccine developed in the UK by Oxford University and AstraZeneca can protect 70.4% of people from becoming ill and – in a surprise result – up to 90% if a lower first dose is used, results from the final trial show.The Oxford vaccine is the third to produce efficacy results, following Pfizer/BioNTech and Moderna whose vaccines we...
Tags: Health, UK, Science, US, Society, World news, Medical Research, Infectious Diseases, Oxford, Astrazeneca, Vaccines and immunisation, Pfizer, Oxford University, Moderna, Coronavirus, Oxford AstraZeneca


Oxford AstraZeneca results open up Covid vaccine to developing countries

Jab can be kept in fridge and is part of global initiative to distribute doses at limited costCoronavirus – latest updatesSee all our coronavirus coverageThe efficacy of the Oxford University/AstraZeneca vaccine opens the way for a cheap and more easily transportable vaccine to be made available to some of the world’s poorest countries.Unlike the Pfizer-BioNTech vaccine, AstraZeneca’s experimental vaccine is already a part of Covax, the global initiative which hopes to distribute some 2bn doses ...
Tags: Health, Science, Society, World news, Medical Research, Infectious Diseases, Global development, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, University of Oxford, Coronavirus, Oxford University AstraZeneca, Oxford AstraZeneca


Moderna vaccine's effectiveness bodes well for Oxford/AstraZeneca jab

Phase 3 success rate of 95% for US firm’s treatment is promising for UK vaccine trialCoronavirus – latest updatesSee all our coronavirus coverageHopes are rising for the Covid jab being developed by Oxford University, after Moderna became the second company to reveal impressive results from its vaccine trials.Interim results from phase 3 clinical trials of the Covid vaccine from US company Moderna has revealed it to be almost 95% effective at preventing the disease. The news followed an announce...
Tags: Health, UK, Science, Germany, US, Society, UK News, World news, Astrazeneca, Pharmaceuticals industry, Vaccines and immunisation, Pfizer, University of Oxford, Oxford University, Moderna, Coronavirus



Filters
show more filters
February - 2021
MoTuWeThFrSaSu
1234567
891011121314
15161718192021
22232425262728
March - 2021
MoTuWeThFrSaSu
1234567
891011121314
15161718192021
22232425262728
293031    
April - 2021
MoTuWeThFrSaSu
   1234
567891011
12131415161718
19202122232425
2627282930